⚠ FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION · QUALIFIED RESEARCHERS 21+
// PB-0029 Peptide Growth Hormone

Sermorelin

GRF(1-29) · endogenous fragment.

Sermorelin is the 1-29 amino-terminal fragment of human GHRH — the shortest sequence retaining full receptor activity. Originally developed and FDA-approved (as Geref) for diagnostic testing of pituitary GH reserve. Supplied as research-grade material with 3rd-party HPLC verification and full Certificate of Analysis per lot.

01

Compound profile.

// CHEMICAL & STRUCTURAL SPEC — SERMORELIN
MOLECULAR FORMULA
C149H246N44O42S
Peptide · growth hormone class.
MOLECULAR WEIGHT
3,357.9 Da
Monoisotopic / reported mass.
CHAIN LENGTH
29 aa
Primary structure residues.
ORIGIN
GHRH(1-29) truncation
Source or discovery context.
STUDIED PATHWAYS
GHRHR
Reported in published literature.
REPORTED HALF-LIFE
~10–20 min
Very short t½.
HPLC PURITY
99.8%
Minimum release spec · typical >99.9%.
APPEARANCE
White lyo.
White to off-white lyophilized form.
// PRIMARY STRUCTURE
Tyr–Ala–Asp–Ala–Ile–Phe–Thr–Asn–Ser–Tyr–Arg–Lys–Val–Leu–Gly–Gln–Leu–Ser–Ala–Arg–Lys–Leu–Leu–Gln–Asp–Ile–Met–Ser–Arg-NH₂

// Growth hormone releasing factor amino acids 1-29, C-amidated. The shortest fragment of endogenous GHRH that retains full biological activity. FDA approved under the name Geref for diagnostic use.
02

What the literature reports.

Sermorelin is the 1-29 amino-terminal fragment of human GHRH — the shortest sequence retaining full receptor activity. Originally developed and FDA-approved (as Geref) for diagnostic testing of pituitary GH reserve.

Reported mechanism

Sermorelin binds the GHRH receptor on anterior pituitary somatotrophs. Unlike the GHRPs (which act at the ghrelin receptor), sermorelin acts via the endogenous GHRH pathway, producing pulsatile, GH-specific stimulation without off-target effects on cortisol, prolactin, or ACTH.

Regulatory status

Sermorelin was FDA-approved as Geref (Serono) for diagnostic use in GH-deficient children, though the brand was discontinued. Currently widely available as a research compound and through compounding pharmacies.

The above summarizes published research literature. This is not medical advice, a protocol, or a recommendation for use. This compound is supplied for laboratory research only.

03

Storage & release.

SHIP TEMP
Ambient
Lyophilized; stable at room temp in transit.
UNOPENED
Refrigerate
Lyophilized, protected from light.
RECONSTITUTED
~28 days
At 2–8°C; never freeze solutions.
RELEASE DOC
COA · per lot
3rd-party analytical · attached at ship.
lab@peptidebros:~$ cat release.sermorelin.SER-26-Q2-0055.log
// lot release record
compound Sermorelin (C149H246N44O42S)
lot.id SER-26-Q2-0055
class peptide
mw.theoretical 3,357.9 Da
mw.observed 3,357.9 Da  [PASS]
purity.hplc 99.91%  [> 99.5% spec]
endotoxin < 0.125 EU/mL  [PASS]
sterility no growth  [PASS]
release.status RELEASED
04

Common questions.

What's the molecular profile?+

Sermorelin is a 29-residue peptide with molecular formula C149H246N44O42S and molecular weight of approximately 3,357.9 Da.

The full structural data and release specifications are in the Compound Profile section above. Every lot ships with an independently verified Certificate of Analysis.

How is purity verified?+

Each lot is independently verified by a 3rd-party analytical laboratory (STERIS Labs, Alcami Analytical, or equivalent) before release. Release specification is HPLC purity ≥ 99.5% (typical > 99.8%), mass spectrometry identity match within ±0.5 Da, water content < 5.0% Karl Fischer, and endotoxin < 0.25 EU/mL by LAL (USP <85>).

Look up the full COA for your lot at coa-lookup.html.

How is the compound shipped and stored?+

All compounds ship at ambient temperature in discreet, tamper-evident packaging. Lyophilized peptide powder is stable at room temperature for typical transit windows, which is why research-grade vendors ship this way. Tracked; signature not required.

Store unopened lyophilized product at 2–8°C protected from light. Once reconstituted, most peptides are stable at 2–8°C for approximately 28 days (compound-dependent).

Is this compound FDA-approved?+

Sermorelin was FDA-approved as Geref (Serono) for diagnostic use in GH-deficient children, though the brand was discontinued. Currently widely available as a research compound and through compounding pharmacies.

All PeptideBros compounds are sold strictly as chemical reference materials for in-vitro laboratory research. They are not for human consumption.

Every lot,
on paper.

HPLC-verified. Mass-spec confirmed. Ambient-stable transit. The paperwork other vendors hope you never ask for.